Jenburkt Pharmaceuticals Ltd
NSE: BSE: 524731
₹1004
(0.93%)
Sun, 08 Mar 2026, 03:16 pm
Market Cap4.43B
PE Ratio13.67
Dividend1.79
Health Technology
Pharmaceuticals: Major
24.5KCompany History
1984
- M/S Jenburkt Pharmaceuticals was established by Mr. Harshad Bhuta along with his brothers.
1985
- The Company was originally incorporated as a Private Limited Company on 10th June.
- Jenburkt Pharmaceuticals started with a turnover of Rs. 39.92 Lacs.
1992
- The group turnover was Rs. 1616.85 lacs.
1993
- The group turnover was over Rs. 2000 Lacs.
1994
- The Company was converted into a Public Limited Company on 4th January.
- The Company obtained a certificate of change of name from the Registrar of Companies on 31st January.
2003
- The company's modern formulation plant at Sihor, Gujarat, has received WHO-GMP certification as laid down by the World Health Organization, Geneva.
2004
- Jenburkt Pharmaceuticals Ltd has declared a dividend at Rs 0.70 per equity share each of Rs 10.
2005
- Jenburkt Pharmaceuticals Ltd has recommended a dividend at 10% on Equity Shares of the Company.
2006
- Jenburkt Pharmaceuticals Ltd has recommended a dividend at 12.5% on Rs 10/- paid up Equity Shares of the Company.
2007
- Jenburkt Pharmaceuticals Ltd has recommended a dividend of 12.5% per equity share of Rs 10/- each.
- The Company is in receipt of a prestigious credit rating Certification from NSIC-CRISIL with the highest possible rating as CRISIL SE 1A.
2008
- The Company has recommended a dividend of 12.5% equity share of Rs 10/-.
2009
- Jenburkt Pharmaceuticals Ltd has recommended a dividend of Rs 1.80 (18%) per equity share of Rs 10/- each.
2010
- Jenburkt Pharmaceuticals Ltd has recommended a dividend of Rs. 3.00 (30%) per equity shares of Rs. 10/- each.
- The Company was bestowed with National Award for Excellence in Cost Management-2009 as the FIRST awardees under the category of the Private Manufacturing-(small) by the Institute of Cost and Works Accountants of India (ICWAI), at New Delhi.
2011
- The Company has recommended a Dividend of Rs. 3.50 (35%) per equity share of Rs. 10/- each.
- The Company was bestowed with National Award for Excellence in Cost Management-2010 as the FIRST awardee under the category of the Private Manufacturing-(small) by the Institute of Cost and Works Accountants of India (ICWAI).
- The Company has been awarded an NSIC-CRISIL rating of NSIC-CRISIL SE-1A on June 30, 2011.
2012
- Jenburkt Pharmaceuticals Ltd has recommended a dividend of Rs. 3.50 (35%) per equity share of Rs. 10/- each.
2013
- Shri. Ashish U. Bhuta has been appointed as the Chairman and Managing Director of the Company
2014
- The Company has recommended a Dividend of Rs. 5.10 (51%) per equity share of Rs. 10/- each.
- Ms. Devangi Sanjeev Shah has been appointed as Woman Director
2020
- Jenburkt launched Favipiravir (Favivent) to fight COVID-19
2022
- The Company Launched a new product ZIXA STRONG on e-commerce websites.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800